(Q43693030)

25 November 2017

title

Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus (English)

1 reference

25 November 2017

0 references

1 reference

systemic immune response

1 reference

rabies virus

1 reference

R Ramya

1

1 reference

25 November 2017

P C Verma

2

1 reference

25 November 2017

V K Chaturvedi

3

1 reference

25 November 2017

P K Gupta

4

1 reference

25 November 2017

K D Pandey

5

1 reference

25 November 2017

M Madhanmohan

6

1 reference

25 November 2017

T R Kannaki

7

1 reference

25 November 2017

R Sridevi

8

1 reference

25 November 2017

B Anukumar

9

1 reference

25 November 2017

language of work or name

English

0 references

publication date

6 February 2009

1 reference

25 November 2017

1 reference

25 November 2017

volume

27

1 reference

25 November 2017

issue

15

1 reference

25 November 2017

page(s)

2138-2143

1 reference

Oral immunization of foxes with avirulent rabies virus mutants

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Potential of polymer microencapsulation technology for vaccine innovation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Biodegradable microspheres as a vaccine delivery system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

The preparation of cultured rabies virus and the production of antiserum for human use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Field trial with oral vaccination of dogs against rabies in the Philippines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Oral vaccination of foxes against rabies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Essential Role of T Cells in the Postexposure Prophylaxis of Rabies in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

Mouse model for abortive rabies infection of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.129

10.1016/J.VACCINE.2009.01.129

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference